<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37383228</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1157149</StartPage><MedlinePgn>1157149</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1157149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1157149</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE) is widely unknown, and the role of autoantibodies is still undetermined.</AbstractText><AbstractText Label="METHODS">To identify brain-reactive autoantibodies possibly related to NPSLE, immunofluorescence (IF) and transmission electron microscopy (TEM) on rat and human brains were performed. ELISA was used to reveal the presence of known circulating autoantibodies, while western blot (WB) was applied to characterize potential unknown autoantigen(s).</AbstractText><AbstractText Label="RESULTS">We enrolled 209 subjects, including patients affected by SLE (n=69), NPSLE (n=36), Multiple Sclerosis (MS, n=22), and 82 age- and gender-matched healthy donors (HD). Autoantibody reactivity by IF was observed in almost the entire rat brain (cortex, hippocampus, and cerebellum) using sera from NPSLE and SLE patients and was virtually negative in MS and HD. NPSLE showed higher prevalence (OR 2.4; p = 0.047), intensity, and titer of brain-reactive autoantibodies than SLE patients. Most of the patient sera with brain-reactive autoantibodies (75%) also stained human brains. Double staining experiments on rat brains mixing patients' sera with antibodies directed against neuronal (NeuN) or glial markers showed autoantibody reactivity restricted to NeuN-containing neurons. Using TEM, the targets of brain-reactive autoantibodies were located in the nuclei and, to a lesser extent, in the cytoplasm and mitochondria. Given the high degree of colocalization between NeuN and brain-reactive autoantibodies, we assumed NeuN was a possible autoantigen. However, WB analysis with HEK293T cell lysates expressing or not expressing the gene encoding for NeuN protein (RIBFOX3) showed that patients' sera carrying brain-reactive autoantibodies did not recognize the NeuN corresponding band size. Among the panel of NPSLE-associated autoantibodies (e.g., anti-NR2, anti-P-ribosomal protein, antiphospholipid) investigated by ELISA assay, only the anti-&#x3b2;2-glycoprotein-I (a&#x3b2;2GPI) IgG was exclusively found in those sera containing brain-reactive autoantibodies.</AbstractText><AbstractText Label="CONCLUSION">In conclusion, SLE and NPSLE patients possess brain-reactive autoantibodies but with higher frequency and titers found in NPSLE patients. Although many target antigens of brain-reactive autoantibodies are still undetermined, they likely include &#x3b2;2GPI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Cocco, Manca, Corda, Angioni, Noli, Congia, Loy, Isola, Chessa, Floris, Lorefice, Saba, Mathieu, Ferri, Cauli and Piga.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cocco</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manca</LastName><ForeName>Elias</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corda</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angioni</LastName><ForeName>Maria Maddalena</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noli</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Congia</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loy</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isola</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chessa</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Floris</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorefice</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, ASSL Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology Department, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathieu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Gian Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cauli</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piga</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, University Clinic, AOU Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences and Public health, University of Cagliari, Monserrato, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001324">Autoantigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020945" MajorTopicYN="Y">Lupus Vasculitis, Central Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001324" MajorTopicYN="N">Autoantigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoantibodies</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">immunofluorescence</Keyword><Keyword MajorTopicYN="N">neurons</Keyword><Keyword MajorTopicYN="N">neuropsychiatric syndromes</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37383228</ArticleId><ArticleId IdType="pmc">PMC10294074</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1157149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. New Engl J Med (2012) 366:573&#x2013;4. doi:&#xa0;10.1056/NEJMc1115196</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1115196</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>ACR . The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum (1999) 42:599&#x2013;608. doi:&#xa0;10.1002/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(199904)42:4&lt;599::AID-ANR2&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">10211873</ArticleId></ArticleIdList></Reference><Reference><Citation>Piga M, Casula L, Perra D, Sanna S, Floris A, Antonelli A, et al. . Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001&#x2013;2012. Lupus (2016) 25:28&#x2013;37. doi:&#xa0;10.1177/0961203315596597</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315596597</ArticleId><ArticleId IdType="pubmed">26199283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zirkzee E, Huizinga T, Bollen E, van Buchem M, Middelkoop H, van de Wee NR, et al. . Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus (2014) 23:31&#x2013;8. doi:&#xa0;10.1177/0961203313512540</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313512540</ArticleId><ArticleId IdType="pubmed">24243776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zirkzee EJM, Steup-Beekman GM, van der Mast RC, Bollen ELEM, van der Wee NJA, Baptist E, et al. . Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy. J Rheumatol (2012) 39:2118&#x2013;26. doi:&#xa0;10.3899/jrheum.120545</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.120545</ArticleId><ArticleId IdType="pubmed">22984275</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol (2019) 15:137&#x2013;52. doi:&#xa0;10.1038/s41584-018-0156-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0156-8</ArticleId><ArticleId IdType="pmc">PMC8023338</ArticleId><ArticleId IdType="pubmed">30659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol (2014) 10:338&#x2013;47. doi:&#xa0;10.1038/nrrheum.2014.15</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2014.15</ArticleId><ArticleId IdType="pubmed">24514913</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortoluzzi A, Scir&#xe8; CA, Bombardieri S, Caniatti L, Conti F, de Vita S, et al. . Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (2015) 54:891&#x2013;8. doi:&#xa0;10.1093/rheumatology/keu384</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu384</ArticleId><ArticleId IdType="pubmed">25339643</ArticleId></ArticleIdList></Reference><Reference><Citation>Govoni M, Hanly JG. The management of neuropsychiatric lupus in the 21st century: still so many unmet needs? Rheumatology (2020) 59:v52&#x2013;62. doi:&#xa0;10.1093/rheumatology/keaa404</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa404</ArticleId><ArticleId IdType="pmc">PMC7719041</ArticleId><ArticleId IdType="pubmed">33280014</ArticleId></ArticleIdList></Reference><Reference><Citation>Segovia-Miranda F, Serrano F, Dyrda A, Ampuero E, Retamal C, Bravo-Zehnder M, et al. . Pathogenicity of lupus anti-ribosomal p antibodies: role of cross-reacting neuronal surface p antigen in glutamatergic transmission and plasticity in a mouse model. Arthritis Rheumatol (2015) 67:1598&#x2013;610. doi:&#xa0;10.1002/art.39081</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39081</ArticleId><ArticleId IdType="pubmed">25709106</ArticleId></ArticleIdList></Reference><Reference><Citation>Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med (1998) 188:29&#x2013;38. doi:&#xa0;10.1084/jem.188.1.29</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.188.1.29</ArticleId><ArticleId IdType="pmc">PMC2525538</ArticleId><ArticleId IdType="pubmed">9653081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirohata S, Tanaka K. Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus. Lupus Sci Med (2019) 6:1&#x2013;6. doi:&#xa0;10.1136/lupus-2019-000359</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2019-000359</ArticleId><ArticleId IdType="pmc">PMC6861108</ArticleId><ArticleId IdType="pubmed">31798919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan H, Chan H, Liang C, Lee H, Su H, Lee A, et al. . Role of low-density lipoprotein in early vascular aging associated with systemic lupus erythematosus. Arthritis Rheumatol (2020) 72(6):972&#x2013;984. doi:&#xa0;10.1002/art.41213</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41213</ArticleId><ArticleId IdType="pubmed">31994323</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang EH, Volpe BT, Mackay M, Aranow C, Watson P, Kowal C, et al. . Selective impairment of spatial cognition caused by autoantibodies to the n-Methyl-d-Aspartate receptor. EBioMedicine (2015) 2:755&#x2013;64. doi:&#xa0;10.1016/j.ebiom.2015.05.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.05.027</ArticleId><ArticleId IdType="pmc">PMC4534689</ArticleId><ArticleId IdType="pubmed">26286205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum (2007) 36:297&#x2013;315. doi:&#xa0;10.1016/j.semarthrit.2006.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2006.11.003</ArticleId><ArticleId IdType="pubmed">17258299</ArticleId></ArticleIdList></Reference><Reference><Citation>Manca E. Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease? Clin Rev Allergy Immunol (2021) 63(2):194&#x2013;209. doi:&#xa0;10.1007/s12016-021-08865-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08865-2</ArticleId><ArticleId IdType="pmc">PMC9464150</ArticleId><ArticleId IdType="pubmed">34115263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 40:1725&#x2013;5. doi:&#xa0;10.1002/art.1780400928</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, et al. . The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun (2016) 74:41&#x2013;72. doi:&#xa0;10.1016/j.jaut.2016.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.06.013</ArticleId><ArticleId IdType="pubmed">27427403</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocco C, Melis GV, Ferri GL. Embedding media for cryomicrotomy: an applicative reappraisal. Appl Immunohistochemistry Mol Morphol (2003) 11:274&#x2013;80. doi:&#xa0;10.1097/00129039-200309000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00129039-200309000-00012</ArticleId><ArticleId IdType="pubmed">12966356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan EKL, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PLC, et al. . Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014&#x2013;2015. Front Immunol (2015) 6:412. doi:&#xa0;10.3389/fimmu.2015.00412</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00412</ArticleId><ArticleId IdType="pmc">PMC4542633</ArticleId><ArticleId IdType="pubmed">26347739</ArticleId></ArticleIdList></Reference><Reference><Citation>Isola M, Ekstr&#xf6;m J, Isola R, Loy F. Melatonin release by exocytosis in the rat parotid gland. J Anat (2019) 234:338&#x2013;45. doi:&#xa0;10.1111/joa.12921</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12921</ArticleId><ArticleId IdType="pmc">PMC6365479</ArticleId><ArticleId IdType="pubmed">30536666</ArticleId></ArticleIdList></Reference><Reference><Citation>Isola M, Lilliu MA, Loy F, Isola R. Diabetic status influences the storage of melatonin in human salivary glands. Anatomical Rec (2018) 301:711&#x2013;6. doi:&#xa0;10.1002/ar.23750</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.23750</ArticleId><ArticleId IdType="pubmed">29236363</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyendijk J, Steens SCA, Ouwendijk WJN, Steup-Beekman GM, Bollen ELEM, van der Grond J, et al. . Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum (2011) 63:722&#x2013;32. doi:&#xa0;10.1002/art.30157</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30157</ArticleId><ArticleId IdType="pubmed">21360502</ArticleId></ArticleIdList></Reference><Reference><Citation>Piga M, Peltz MT, Montaldo C, Perra D, Sanna G, Cauli A, et al. . Twenty-year brain magnetic resonance imaging follow-up study in systemic lupus erythematosus: factors associated with accrual of damage and central nervous system involvement. Autoimmun Rev (2015) 14:510&#x2013;6. doi:&#xa0;10.1016/j.autrev.2015.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2015.01.010</ArticleId><ArticleId IdType="pubmed">25617815</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro-Checa C, Kumar S, Ramiro S, Beaart-van de Voorde LJ, Eikenboom J, Ronen I, et al. . Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort. Lupus (2019) 28:94&#x2013;103. doi:&#xa0;10.1177/0961203318816819</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318816819</ArticleId><ArticleId IdType="pmc">PMC6304692</ArticleId><ArticleId IdType="pubmed">30526327</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Delgado NP, V&#xe1;squez G, Ortiz-Reyes BL. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. AutoimmunRev (2019) 18:426&#x2013;32. doi:&#xa0;10.1016/j.autrev.2018.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.12.004</ArticleId><ArticleId IdType="pubmed">30763633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Zehnder M, Toledo EM, Segovia-Miranda F, Serrano FG, Benito MJ, Metz C, et al. . Anti-ribosomal p protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis Rheumatol (2015) 67:204&#x2013;14. doi:&#xa0;10.1002/art.38900</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38900</ArticleId><ArticleId IdType="pubmed">25302407</ArticleId></ArticleIdList></Reference><Reference><Citation>Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, et al. . Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci (2010) 107:18569&#x2013;74. doi:&#xa0;10.1073/pnas.1006980107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006980107</ArticleId><ArticleId IdType="pmc">PMC2972998</ArticleId><ArticleId IdType="pubmed">20921396</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronti B, Pittoni V, Palladini G, Valesini G. Anti-&#x3b2;2GPI antibodies bind to central nervous system. J Neurological Sci (1998) 156:211&#x2013;9. doi: 10.1016/S0022-510X(98)00027-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00027-6</ArticleId><ArticleId IdType="pubmed">9588860</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Hernandez A, Ortiz-Orendain J, Alvarez-Palazuelos LE, Gonzalez-Lopez L, Gamez-Nava JI, Zavala-Cerna MG. Seizures in systemic lupus erythematosus: a scoping review. Seizure (2021) 86:161&#x2013;7. doi:&#xa0;10.1016/j.seizure.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2021.02.021</ArticleId><ArticleId IdType="pubmed">33626435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KK, Adelstein RS, Kawamoto S. Identification of neuronal nuclei (NeuN) as fox-3, a new member of the fox-1 gene family of splicing factors. J Biol Chem (2009) 284:31052&#x2013;61. doi:&#xa0;10.1074/jbc.M109.052969</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.052969</ArticleId><ArticleId IdType="pmc">PMC2781505</ArticleId><ArticleId IdType="pubmed">19713214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Wang HY, Huang DF, Hsieh PF, Lin MY, Chou CH, et al. . Neuronal splicing regulator RBFOX3 (NeuN) regulates adult hippocampal neurogenesis and synaptogenesis. PloS One (2016) 11:1&#x2013;17. doi:&#xa0;10.1371/journal.pone.0164164</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164164</ArticleId><ArticleId IdType="pmc">PMC5049801</ArticleId><ArticleId IdType="pubmed">27701470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnat HB, Nochlin D, Born DE. Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system. Brain Dev (1998) 20:88&#x2013;94. doi:&#xa0;10.1016/S0387-7604(97)00111-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0387-7604(97)00111-3</ArticleId><ArticleId IdType="pubmed">9545178</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyer A, Schilling K. Developmental and cell type-specific expression of the neuronal marker NeuN in the murine cerebellum. J Neurosci Res (2003) 73:400&#x2013;9. doi:&#xa0;10.1002/jnr.10655</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10655</ArticleId><ArticleId IdType="pubmed">12868073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal D, Reinthaler EM, Altm&#xfc;ller J, Toliat MR, Thiele H, N&#xfc;rnberg P, et al. . RBFOX1 and RBFOX3 mutations in rolandic epilepsy. PloS One (2013) 8:1&#x2013;6. doi:&#xa0;10.1371/journal.pone.0073323</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073323</ArticleId><ArticleId IdType="pmc">PMC3765197</ArticleId><ArticleId IdType="pubmed">24039908</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas CH, Calvez M, Babu R, Brown A. Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND). Neurosci Lett (2014) 558:97&#x2013;102. doi:&#xa0;10.1016/j.neulet.2013.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.10.037</ArticleId><ArticleId IdType="pmc">PMC3880598</ArticleId><ArticleId IdType="pubmed">24215932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HY, Hsieh PF, Huang DF, Chin PS, Chou CH, Tung CC, et al. . RBFOX3/NeuN is required for hippocampal circuit balance and function. Sci Rep (2015) 5:1&#x2013;16. doi:&#xa0;10.1038/srep17383</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17383</ArticleId><ArticleId IdType="pmc">PMC4664964</ArticleId><ArticleId IdType="pubmed">26619789</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusel&#x2019;nikova VV, Korzhevskiy DE. NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae (2015) 7:42&#x2013;7. doi:&#xa0;10.32607/20758251-2015-7-2-42-47</Citation><ArticleIdList><ArticleId IdType="doi">10.32607/20758251-2015-7-2-42-47</ArticleId><ArticleId IdType="pmc">PMC4463411</ArticleId><ArticleId IdType="pubmed">26085943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortoluzzi A, Fanouriakis A, Appenzeller S, Costallat L, Scir&#xe8; CA, Murphy E, et al. . Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study. BMJ Open (2017) 7(5):e015546. doi:&#xa0;10.1136/bmjopen-2016-015546</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015546</ArticleId><ArticleId IdType="pmc">PMC5730002</ArticleId><ArticleId IdType="pubmed">28554934</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>